Alternating-pressure bed mattress system Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

alternating-pressure bed mattress system

alrick manufacturing & imports - 63241 - alternating-pressure bed mattress system - an alternating pressure mattress with dedicated electric pump intended to relieve pressure on susceptible pressure points of patients confined to bed.

Alternating-pressure bed mattress system Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

alternating-pressure bed mattress system

care quip - 63241 - alternating-pressure bed mattress system - an alternating-pressure bed mattress and a dedicated electric pump, which also functions as the control unit, designed to actively alternate a bed occupant's bed-contact points, typically to relieve pressure points for comfort and to prevent pressure sores.

Alternating-pressure bed mattress system Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

alternating-pressure bed mattress system

boian surgical pty ltd - 63241 - alternating-pressure bed mattress system - a device designed to actively alternate a bed occupant's bed-contact points for the purpose of relieving pressure on those areas, improving patient comfort and preventing the occurrence of pressure sores.

Soluprick Alternaria alternata (A.tenuis) 10HEP solution for skin prick test Lielbritānija - angļu - MHRA (Medicines & Healthcare Products Regulatory Agency)

soluprick alternaria alternata (a.tenuis) 10hep solution for skin prick test

a.tenuis) 10hep solution for skin prick test (alk-abello ltd - alternaria alternata (a.tenuis) allergen extract - solution for skin-prick test

Alustal Alternaria extract Jaunzēlande - angļu - Medsafe (Medicines Safety Authority)

alustal alternaria extract

ebos group ltd - allergen extracts 0.1 ic/ml (alternaria alternata (50%), alternaria longipes (50%) extracts); allergen extracts 1 ic/ml (alternaria alternata (50%), alternaria longipes (50%) extracts); allergen extracts 10 ic/ml (alternaria alternata (50%), alternaria longipes (50%) extracts) - solution for injection - active: allergen extracts 0.1 ic/ml (alternaria alternata (50%), alternaria longipes (50%) extracts) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water active: allergen extracts 1 ic/ml (alternaria alternata (50%), alternaria longipes (50%) extracts) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water active: allergen extracts 10 ic/ml (alternaria alternata (50%), alternaria longipes (50%) extracts) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water

Alustal Alternaria extract Jaunzēlande - angļu - Medsafe (Medicines Safety Authority)

alustal alternaria extract

ebos group ltd - allergen extracts 0.01 ic/ml (alternaria alternata (50%), alternaria longipes (50%) extracts) - solution for injection - 0.01 ic/ml - active: allergen extracts 0.01 ic/ml (alternaria alternata (50%), alternaria longipes (50%) extracts) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water

Alustal Alternaria extract Jaunzēlande - angļu - Medsafe (Medicines Safety Authority)

alustal alternaria extract

ebos group ltd - allergen extracts 10 ic/ml (alternaria alternata (50%), alternaria longipes (50%) extracts) - solution for injection - 10 ic/ml - active: allergen extracts 10 ic/ml (alternaria alternata (50%), alternaria longipes (50%) extracts) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water

TREATMENT SET TS336437 injection, solution Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

treatment set ts336437 injection, solution

antigen laboratories, inc. - alternaria alternata (unii: 52b29rec7h) (alternaria alternata - unii:52b29rec7h), ambrosia trifida pollen (unii: ku1v1898xx) (ambrosia trifida pollen - unii:ku1v1898xx), ambrosia artemisiifolia pollen (unii: k20y81aco3) (ambrosia artemisiifolia pollen - unii:k20y81aco3), ambrosia psilostachya pollen (unii: rx18m46k8l) (ambrosia psilostachya pollen - unii:rx18m46k8l), dermatophagoides pteronyssinus (unii: 57l1z5378k) (dermatophagoides pteronyssinus - unii:57l1z5378k), carya alba pollen (unii: g2a764t54b - alternaria alternata 0.002 g in 1 ml - when the natural exposure to elevated aeroallergens produces symptoms as described under clinical pharmacology, specific diagnosis and therapeutic procedures are indicated. clearly, important clues to the cause of a person's allergic condition can be gleaned from a thorough history and careful physical examination. diagnostic tests - in vitro or in vivo - serve only to confirm the physician's suspicions or to improve investigative skills. specific diagnosis is especially indicated when the patient's symptoms are not controlled by medication. when immunotherapy is contemplated demonstration of sensitivity to a specific allergenic extract is necessary. an orderly approach to the use of diagnostic tests usually begins with direct skin testing. 5,6,11 this product is not intended for treatment of patients who do not manifest immediate hypersensitivity reactions to the allergenic extract following skin testing. there are no absolute contraindications; however, extreme caution is necessary when using diagnostic ski

TREATMENT SET TS336667 injection, solution
TREATMENT SET TS336682 injection, solution
TREATMENT SET TS336683 injection, soluti Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

treatment set ts336667 injection, solution treatment set ts336682 injection, solution treatment set ts336683 injection, soluti

antigen laboratories, inc. - alternaria alternata (unii: 52b29rec7h) (alternaria alternata - unii:52b29rec7h), ambrosia artemisiifolia pollen (unii: k20y81aco3) (ambrosia artemisiifolia pollen - unii:k20y81aco3), felis catus hair (unii: 1564hd0n96) (felis catus hair - unii:1564hd0n96), canis lupus familiaris hair (unii: 05s7l91ztr) (canis lupus familiaris hair - unii:05s7l91ztr), phleum pratense pollen (unii: 65m88rw2eg) (phleum pratense pollen - unii:65m88rw2eg) - alternaria alternata 0.002 g in 1 ml - when the natural exposure to elevated aeroallergens produces symptoms as described under clinical pharmacology, specific diagnosis and therapeutic procedures are indicated. clearly, important clues to the cause of a person's allergic condition can be gleaned from a thorough history and careful physical examination. diagnostic tests - in vitro or in vivo - serve only to confirm the physician's suspicions or to improve investigative skills. specific diagnosis is especially indicated when the patient's symptoms are not controlled by medication. when immunotherapy is contemplated demonstration of sensitivity to a specific allergenic extract is necessary. an orderly approach to the use of diagnostic tests usually begins with direct skin testing. 5,6,11 this product is not intended for treatment of patients who do not manifest immediate hypersensitivity reactions to the allergenic extract following skin testing. there are no absolute contraindications; however, extreme caution is necessary when using diagnostic ski

TREATMENT SET TS343825 injection, solution
TREATMENT SET TS343826 injection, solution
TREATMENT SET TS344001 injection, soluti Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

treatment set ts343825 injection, solution treatment set ts343826 injection, solution treatment set ts344001 injection, soluti

antigen laboratories, inc. - alternaria alternata (unii: 52b29rec7h) (alternaria alternata - unii:52b29rec7h), aspergillus fumigatus (unii: x88df51t48) (aspergillus fumigatus - unii:x88df51t48), cochliobolus sativus (unii: 3ln5b70u4w) (cochliobolus sativus - unii:3ln5b70u4w), cladosporium cladosporioides (unii: 4zwy20gtgo) (cladosporium cladosporioides - unii:4zwy20gtgo), penicillium chrysogenum var. chrysogenum (unii: 3y1pe1gcig) (penicillium chrysogenum var. chrysogenum - unii:3y1pe1gcig) - alternaria alternata 0.01 g in 1 ml - when the natural exposure to elevated aeroallergens produces symptoms as described under clinical pharmacology, specific diagnosis and therapeutic procedures are indicated. clearly, important clues to the cause of a person's allergic condition can be gleaned from a thorough history and careful physical examination. diagnostic tests - in vitro or in vivo - serve only to confirm the physician's suspicions or to improve investigative skills. specific diagnosis is especially indicated when the patient's symptoms are not controlled by medication. when immunotherapy is contemplated demonstration of sensitivity to a specific allergenic extract is necessary. an orderly approach to the use of diagnostic tests usually begins with direct skin testing. 5,6,11 this product is not intended for treatment of patients who do not manifest immediate hypersensitivity reactions to the allergenic extract following skin testing. there are no absolute contraindications; however, extreme caution is necessary when using diagnostic ski